Antitumor effect and tolerability of NVP-AUY922 in a BT sorted by
relevance

Admin13.07.2021

Antitumor effect and tolerability of NVP-AUY922 in a BT

9006
Admin27.09.2021

Antitumor effect and tolerability of NVP-AUY922 in a BT

3908
Admin12.09.2021

NVP-AUY922: a small molecule HSP90 inhibitor with potent

8406
Admin26.08.2021

NVP-AUY922: a small molecule HSP90 inhibitor with potent

2501
Admin20.08.2021

NVP-AUY922: a small molecule HSP90 inhibitor with potent

204
Admin19.09.2021

NVP-AUY922: a small molecule HSP90 inhibitor with potent

5602
Admin29.09.2021

(PDF) X66, a novel N-terminal heat shock protein 90

6601
Admin12.08.2021

(PDF) X66, a novel N-terminal heat shock protein 90

Admin05.08.2021

(PDF) Preclinical Antitumor Activity of the Orally

802
Admin15.09.2021

(PDF) Preclinical Antitumor Activity of the Orally

8303
Admin10.10.2021

(PDF) X66, a novel N-terminal heat shock protein 90

2007
Admin20.09.2021

(PDF) X66, a novel N-terminal heat shock protein 90

1908
Admin25.08.2021

X66, a novel N-terminal heat shock protein 90 inhibitor

8702
Admin30.09.2021

Preclinical Antitumor Activity of the Orally Available

3307
Admin29.09.2021

NVP-AUY922: a small molecule HSP90 inhibitor with potent

8803
Admin16.09.2021

Preclinical Antitumor Activity of the Orally Available

2707
Admin15.08.2021

NVP-AUY922: a small molecule HSP90 inhibitor with potent

2106